Preparation of thalidomide nano-flakes by supercritical antisolvent with enhanced mass transfer

Particuology

Volumn 10, Issue 1, 2012, Pages 17-23

  Jin, Heyang ^a   Hemingway, Melinda ^b   Gupta, Ram B ^b   Xia, Fei ^a   Zhao, Yaping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b AUBURN UNIVERSITY   (United States)

Author keywords

Anti solvent; Nano flakes; Polymorph; Supercritical; Thalidomide; Ultrasound

Indexed keywords

ANTI-SOLVENTS; NANO-FLAKES; POLYMORPH; SUPER-CRITICAL; THALIDOMIDE;

BIOCHEMISTRY; SUPERCRITICAL FLUID EXTRACTION; ULTRASONICS;

OPTICAL GLASS;

EID: 84857360603     PISSN: 16742001     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.partic.2011.05.003     Document Type: Article

References (35)

1. M. Bahrami, and S. Ranjbarian Production of micro-and nano-composite particles by supercritical carbon dioxide Journal of Supercritical Fluids 40 2007 263 283 (Pubitemid 46172528)
2. S. Beach, D. Latham, C. Sidgwick, M. Hanna, and P. York Control of the physical form of salmeterol xinafoate Organic Process Research and Development 3 1999 370 376
3. W. Bensinger Initial therapy of multiple myeloma in patients who are candidates for stem cell transplantation Current Treatment Options in Oncology 8 2 2007 135 143
4. J. Bleich, P. Kleinebudde, and B.W. Mueller Influence of gas density and pressure on microparticles produced with the ASES process International Journal of Pharmaceutics 106 1 1994 77 84 (Pubitemid 24110067)
5. M.R. Caira, S.A. Botha, and D.R. Flanagan Polymorphism of n-(2,6-dioxo-3-piperidyl)phthalimide(thalidomide) - Structural characterization of a second monoclinic racemic modification The Journal of Chemical Crystallography 24 1994 95 99
6. A. Candoni, A. Raza, N. Galili, E. Simeone, S. Buttignol, and F. Silvestri Thalidomide alone or in combination with other agents for the treatment of myelodysplastic syndromes (MDS) Leukemia Research 31 Suppl. 1 2007 119
7. J.P. Carini, C. Pavei, A.P.C. Silva, G. Machado, A.S. Mexias, and V.P. Pereira Solid state evaluation of some thalidomide raw materials International Journal of Pharmaceutics 372 2009 17 23
8. 2 antisolvent with enhanced mass transfer International Journal of Pharmaceutics 228 2001 19 31 (Pubitemid 32905362)
9. P. Chattopadhyay, and R.B. Gupta Protein nanoparticles formation by supercritical antisolvent with enhanced mass transfer AIChE Journal 48 2002 235 244 (Pubitemid 37442371)
10. P. Cipriani, and C.Y. Smith Characterization of thalidomide using Raman spectroscopy Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 69 2 2007 333 337
11. D.J. Dixon, and K.P. Johnston Formation of microporous polymer fibers and oriented fibrils by precipitation with a compressed fluid antisolvent Journal of Applied Polymer Science 50 11 1993 1929 1942
12. D.J. Dixon, G. Luna-Bercenas, and K.P. Johnston Microcellular microspheres and microballoons by precipitation with a vapour-liquid compressed fluid antisolvent Polymer 35 1994 3998 4005
13. A.D. Edwards, B.Y. Shekunov, A. Kordikwsi, R.T. Forbes, and P. York Crystallization of pure anhydrous polymorphs of carbamazepine by solution enhanced dispersion with supercritical fluids (SEDS™) Journal of Pharmaceutical Science 90 2001 1115 1124
14. R. Falk, T. Randolph, J.D. Meyer, R.M. Kelly, and M.C. Manning Controlled release of ionic compounds from poly (l-lactide) microspheres produced by precipitation with a compressed antisolvent Journal of Controlled Release 44 1997 77 85 (Pubitemid 27051336)
15. FDA Guidance for industry, ANDAs, pharmaceutical solid polymorphism, chemistry, manufacturing, and controls information 2007 U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) FDA, Rockville pp. 1-10
16. M. García-Carrasco, S. Fuentes-Alexandro, R.O. Escárcega, J. Rojas-Rodriguez, and L.E. Escobar Efficacy of thalidomide in systemic onset juvenile rheumatoid arthritis Joint Bone Spine 74 5 2007 500 503 (Pubitemid 47595468)
17. G. Giron Thermal-analysis and calorimetric methods in the characterization of polymorphs and solvates Thermochimica Acta 248 1995 1 59
18. D.J.W. Grant Theory and origin of polymorphism H.G. Brittain, Polymorphism in pharmaceutical solids 1999 Marcel Dekker Inc. New York 1 34
19. Gupta, R. B., & Chattopadhyay, P. (2001). Method of forming nanoparticles and microparticles of controllable size using supercritical fluids with enhanced mass transfer. U.S. Patent No. 6620351.
20. S.S. Iyengar, N.V. Phadnis, and R. Suryanarayanan Quantitative analyses of complex pharmaceutical mixtures by the Rietveld method Powder Diffraction 16 2001 20 24
21. A. Jounela, P. Pentikainen, and A. Sothmann Effect of particle size on the bioavailability of digoxin European Journal of Clinical Pharmacology 8 1975 365 370
22. F. Lara-Ochoa, G. Espinosa Pérez, and F. Mijangos-Santiago Calorimetric determinations and theoretical calculations of polymorphs of thalidomide Journal of Molecular Structure 840 2007 97 106 (Pubitemid 47299233)
23. G.G. Liversidge, and K.C. Cundy Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: Absolute oral bioavailability of nanocrystalline danzol in beagle dogs International Journal of Pharmaceutics 125 1995 91 97
24. Manning, M. C., Randolph, T. W., Shefter, E., & Falk, R. F. (1998). Solubilization of pharmaceutical substances in an organic solvent and preparation of pharmaceutical powders using the same. U.S. Patent No. 5770559.
25. D.W. Matson, J.L. Fulton, R.C. Petersen, and R.D. Smith Rapid expansion of supercritical fluid solution: Solute formation of powders, thin films and fibers Industrial & Engineering Chemistry Research 26 11 1987 2298 2306
26. S. Mawson, S. Kanakia, and K.P. Johnston Coaxial nozzle for control of particle morphology in precipitation with a compressed fluid antisolvent Journal of Applied Polymer Science 64 1997 2105 2118 (Pubitemid 127560484)
27. M. Melchert, and A. List The thalidomide saga The International Journal of Biochemistry & Cell Biology 39 7-8 2007 1489 1499 (Pubitemid 47031027)
28. N. Rasenack, and B.W. Muller Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs Pharmaceutical Research 19 2002 1894 1900 (Pubitemid 36016039)
29. J.C. Reepmeyer, M.O. Rhodes, D.C. Cox, and J.V. Silverton Characterization and crystal-structure of 2 polymorphic forms of racemic thalidomide Journal of the Chemical Society Perkin Transactions 2 1994 2063 2067
30. G.P. Sanganwar, and R.B. Gupta Enhancement of shelf life and handling properties of drug nanoparticles: Nanoscale mixing of itraconazole with silica Industrial & Engineering Chemistry Research 47 2008 4717 4725
31. S. Singhal, J. Mehta, R. Desikan, D. Ayers, P. Roberson, and P. Eddlemon Antitumor activity of thalidomide in refractory multiple myeloma The New England Journal of Medicine 341 21 1999 1565 1571
32. W.K. Snavely, B. Subramaniam, R.A. Rajewski, and M.R. Defelippis Micronization of insulin from halogenated alcohol solution using supercritical carbon dioxide as an antisolvent Journal of Pharmaceutical Science 91 9 2002 2026 2039 (Pubitemid 36254938)
33. B. Subramaniam, R.A. Rajewski, and K. Snavely Pharmaceutical processing with supercritical carbon dioxide Journal of Pharmaceutical Science 86 1997 885 890 (Pubitemid 27344044)
34. S.R. Vippagunta, H.G. Brittain, and D.J.W. Grant Crystalline solids Advanced Drug Delivery Reviews 48 2001 3 26 (Pubitemid 32452290)
35. S.D. Yeo, G.B. Lim, P.G. Debenedetti, and H. Bernstein Formation of microparticulate protein powders using a supercritical fluid antisolvent Biotechnology and Bioengineering 41 1993 341 346 (Pubitemid 23032518)